Sindrome.del.Ovario.Poliquistico

54 Síndrome del Ovario Poliquístico
lence and features of the polycystic
ovary syndrome in an unselected population.
J Clin Endocrinol Metab. 2004;
89:2745-9.
4
Strauss III JF. Some New Thoughts on
the pathophysiology and genetics of
polycystic ovary syndrome. Ann N Y
Acad Sci. 2003;997(1):42-8.
5
Cooper HE, Spellacy WN, Prem KA,
Cohen WD. Hereditary factors in Stein-
Leventhal Syndrome. Am Obstet Gynecol.
1968;100:371-82.
6
Carey AH, Chan KL, Short F, White D,
Williamson R, Franks S. Evidence of a
single gene effect causing polycystic
ovaries and male pattern baldness. Clin
Endocrinol (Oxf). 1993;386:653-8.
7
Govind A, Obhrai MS, Clayton RN.
Polycystic ovarios are inherited as an
autosomal dominant trait: analysis of 29
polycystic ovary syndrome and 10 control
familias. J Clin Endocrinol Metab.
1999;811:38-43.
8
Wild RA, Umstot ES, Andersen RN, Ranney
GB, Givens JR. Androgen parameters
and their correlation with body weight
in one hundred thirty-eight women
thought to have hyperandrogenism. Am
J Obstet Gynecol. 1983;146:606-6.
9
Simpson ER, Mahendroo MS, Means
GD, Kilgore MW, Hinshelwood MM,
Graham-Lorence S, et al. Aromatase cytochrome
P450, the enzyme responsible
for estrogens biosynthesis. Endocr Rev.
1994;15:342-55.
10
Sparkes RS, Mohandas T, Chen S,
Besman MJ, Zollman S, Shively JE.
Assignment of the aromatase gene to
human chromosome 15q21. Cytogenet
Cell Genet. 1987;46:696-7.
11
Urbanek M, Legro RS, Discroll DA, Azziz
R, Ehrmann DA, Norman RJ, et al. Thirty-seven
candidate genes for polycystic
ovary syndrome: strongest evidence for
linkage is with follistatin. Proc Natl Acad
Sci USA. 1999;9615:8573-8.
12
Wickenheisser JK, Nelson-Degrave VL,
McAllister JM. Dysregulation of Cytochrome
P450 17 (alpha)-Hydroxylase
Messenger Ribonucleic Acid Stability in
Theca Cells Isolated from Women with
Polycystic Ovary Syndrome. J Clin Endocrinol
Metab. 2005 Mar;90(3):1720-7.
13
Gharani N, Waterworth DM, Williamson
R, Franks S. 5’polymorphism of the
CYP17 gene is not associated with serum
testosterone levels in women with polycystic
ovaries. J Clin Endocrinol Metab.
1996;8111:4174.
14
Diamanti-Kandarakis E, Bartzis MI,
Zapanti ED, Spina GG, Filandra FA,
Tsianatili TC, et al. Polymorphism T-C
(-34 bp) of gene CYP17 promoter in
Greek patients with polycystic ovary
syndrome. Fertil Steril. 1999;713:431-5.
15
Kahasar-Miller M, Boots LR, Bartolucci
A, Azziz R. Role of a CYP17 polymorphism
in the regulation of circulating
dehydroepiandrosterone sulfate levels in
women with polycystic ovary syndrome.
Fertil Steril. 2004 Oct;82(4):973-5.
16
Witchel SF, Lee PA, Suda-Hartman M,
Hoffman EP. Hyperandrogenism and
manifesting heterozygotes for 21-hydroxylase
deficiency. Biochem Mol Med.
1997;62:151-8.
17
Escobar-Morreale HF, San Millán JL,
Smith RR, Sancho J, Witchel SF. The
presence of 21-hydroxylase deficiency
carrier status in hirsute women: phenotype-genotype
correlations. Fertil Steril.
1999;72:629-38.
18
Azziz R, Owerbach D. Molecular abnormalities
of the 21-hydroxilase gene in
hyperandrogenic women with an exaggerated
17-hydroxyprogesterone response
to short-term adrenal stimulation. Am J
Obstet Gynecol. 1995;172(3):914-8.
19
Mifsud A, Ramírez S, Yong EL. Androgen
receptor gene CAG trinucleotide repeats
in anovulatory infertility and polycystic
ovaries. J Clin Endocrinol Metab. 2000;
859:3484-8.
20
Xita N, Tsatsoulis A, Chatzikyriakidou
A, Georgiou I. Association of the Sex
Hormone-Binding Globulin (SHBG)
gene with polycystic ovary syndrome
and relation to SHBG serum levels. J